We aimed to produce a comprehensive update on clinical and biological data regarding two rare lymphoid neoplasms, B and T prolymphocytic leukemias, and assess therapeutic management in the light of new molecular insights and the advent of targeted therapies
Mature T-cell leukemias represent rare, but increasingly recognized diseases of which, compared to t...
International audienceLarge granular lymphocyte (LGL) leukemia has been recognized in the World Heal...
BackgroundT-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive disease. In this study, we...
We aimed to produce a comprehensive update on clinical and biological data regarding two rare lympho...
T and B subtypes of prolymphocytic leukemias (PLLs) are rare, highly aggressive lymphoid malignancie...
T- and B-cell subtypes of prolymphocytic leukemia (PLL) are rare, aggressive lymphoid malignancies w...
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive T-cell malignancy. T-PLL can be dist...
Prolymphocytic leukaemias of B and T cell subtype are rare diseases. Despite recent advances in immu...
Review on T-cell prolymphocytic leukemia (T-PLL), with data on clinics, and the genes involved
T-cell prolymphocytic leukemia (T-PLL) is the most common mature T-cell leukemia. It is a typically ...
A case of prolymphocytic leukemia (PL) is reported, which showed a good response to a new antiblasti...
International audienceB-cell prolymphocytic leukemia (B-PLL) is a rare hematological disorder whose ...
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma. The diagnosis of T-PLL is m...
Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal prolife...
T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinic...
Mature T-cell leukemias represent rare, but increasingly recognized diseases of which, compared to t...
International audienceLarge granular lymphocyte (LGL) leukemia has been recognized in the World Heal...
BackgroundT-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive disease. In this study, we...
We aimed to produce a comprehensive update on clinical and biological data regarding two rare lympho...
T and B subtypes of prolymphocytic leukemias (PLLs) are rare, highly aggressive lymphoid malignancie...
T- and B-cell subtypes of prolymphocytic leukemia (PLL) are rare, aggressive lymphoid malignancies w...
T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive T-cell malignancy. T-PLL can be dist...
Prolymphocytic leukaemias of B and T cell subtype are rare diseases. Despite recent advances in immu...
Review on T-cell prolymphocytic leukemia (T-PLL), with data on clinics, and the genes involved
T-cell prolymphocytic leukemia (T-PLL) is the most common mature T-cell leukemia. It is a typically ...
A case of prolymphocytic leukemia (PL) is reported, which showed a good response to a new antiblasti...
International audienceB-cell prolymphocytic leukemia (B-PLL) is a rare hematological disorder whose ...
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell lymphoma. The diagnosis of T-PLL is m...
Leukemia, the most common cancer in children, is a hematological malignancy caused by clonal prolife...
T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinic...
Mature T-cell leukemias represent rare, but increasingly recognized diseases of which, compared to t...
International audienceLarge granular lymphocyte (LGL) leukemia has been recognized in the World Heal...
BackgroundT-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive disease. In this study, we...